Skip to content

5-MeO-DMT: all studies

Page 38 of 110: studies 371 to 380 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

The possible place for psychedelics in pharmacotherapy of mental disorders.

Pharmacological Reports December 1, 2023 Adam Wojtas 10 citations

Since its emergence in the 1960s, the serotonergic theory of depression bore fruit in the discovery of a plethora of antidepressant drugs affecting the lives of millions of patients. While crucial in the history of drug development, recent studies undermine the effectiveness of currently used antidepressant drugs in comparison to placebo, emphasizing the long time it takes to initiate the...

Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the "God Molecule".

Pharmaceuticals June 2, 2023 Ahmed Al-Imam, Marek A Motyka, Beata Hoffmann et al. 6 citations

Aboriginals of Latin America have used DMT (N,N-dimethyltryptamine) in ritualistic ceremonies for centuries. Nevertheless, there are limited data on web users' interest concerning DMT. We aim to review the literature and explore the spatial-temporal mapping of online search behavior concerning DMT, 5-MeO-DMT, and the Colorado River toad via Google Trends over the past 10 years (2012-2022) while...

DOI: 10.3390/ph16060831 (opens in new tab) Full text (opens in new tab) Incilius alvarius 5-Methoxy-N,N-Dimethyltryptamine Colorado river toad Sonoran desert toad +4

This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience.

Frontiers in Psychology 2023 Pascal Michael, David Luke, Oliver Robinson 19 citations

Much research has focused on the modeling of the near-death experience (NDE) by classical and atypical psychedelics; however, to date, no study has reported on the relationship between the NDE and the experience induced by the highly potent, endogenous psychedelic drug 5-Methoxy-DMT (5MeO-DMT). This article presents a case study of an individual who is popularly documented to have had a...

Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.

Bioorganic & Medicinal Chemistry Letters February 1, 2016 Nicholas V. Cozzi, Paul F. Daley 24 citations

N,N-Diallyltryptamine (DALT) and 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT) are two tryptamines synthesized and tested by Alexander Shulgin. In self-experiments, 5-MeO-DALT was reported to be psychoactive in the 12-20mg range, while the unsubstituted compound DALT had few discernible effects in the 42-80 mg range. Recently, 5-MeO-DALT has been used in nonmedical settings for its psychoactive...

DOI: 10.1016/j.bmcl.2015.12.053 (opens in new tab) Full text (opens in new tab) 5-Methoxy-N,N-Diallyltryptamine Dalt Hallucinogen Psychopharmacology +9

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Journal of Neural Transmission April 26, 2013 Ede Frecska, Attila Szabo, Michael J. Winkelman et al. 107 citations

N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of plant origin. It has also been found in animal tissues and regarded as an endogenous trace amine transmitter. The vast majority of research on DMT has targeted its psychotropic/psychedelic properties with less focus on its effects beyond the nervous system. The recent discovery that DMT is an...

DOI: 10.1007/s00702-013-1024-y (opens in new tab) DMT N-dimethyltryptamine Therapeutic potential Medical applications +19

Sudden death associated with intravenous injection of toad extract.

Forensic Science International July 1, 2009 Chris Kostakis, Roger W Byard 56 citations

A 24-year-old male died suddenly following the intravenous injection of what was believed to be the ring-derivate amphetamine 'ecstasy' (MDMA). Toxicological analyses of the victim's blood and the injected material, however, failed to reveal MDMA, but showed instead low levels of bufotenine, a tryptamine derivative alkaloid found in the secretions of various toads. In addition, resibufogenin,...

DOI: 10.1016/j.forsciint.2009.02.006 (opens in new tab) Full text (opens in new tab) Toad venom Drug adulteration Drug contamination Illicit drug mixtures +21

The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.

Pharmacology, Biochemistry, and Behavior July 1, 1999 Jerrold C Winter, Scott Helsley, David Fiorella et al. 14 citations

In a previous study it was observed that fluoxetine potentiates the stimulus effects of lysergic acid diethylamide (LSD). In the present investigation, stimulus control was established in groups of rats using as training drugs the hallucinogens lysergic acid diethylamide (LSD); 0.1 mg/kg), (-)-2,5-dimethoxy-4-methylamphetamine [(-)-DOM; 0.56 mg/kg], ibogaine (10 mg/kg), and...

Identity of a New World Psychoactive Toad

Ancient Mesoamerica 1992 Wade Davis, Andrew T. Weil 33 citations

AbstractAnthropologists have long speculated that ancient peoples of Mesoamerica used a toad,Bufo marinus, as a ritual intoxicant. This hypothesis rests on many iconographic and mythological representations of toads and on a number of speculative ethnographic reports. We rejectB. marinusas a candidate for such use because of the toxicity of its venom. A more likely candidate is the Sonoran...

DOI: 10.1017/s0956536100002297 (opens in new tab) 5-MEO-DMT Ancient mesoamerican rituals Sonoran desert toad Ethnopharmacology

Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.

JAMA October 26, 2026 David Feifel, Mathieu Seynaeve, Wiesław Jerzy Cubała et al.

Psychedelics represent a potential breakthrough for treatment-resistant depression; however, the prolonged in-clinic monitoring required for compounds such as psilocybin and lysergic acid diethylamide is a logistical hurdle to widespread use. Intranasal mebufotenin (5-methoxy-N,N-dimethyltryptamine), a 5-hydroxytryptamine 1A (5-HT1A) and 5-HT2A agonist associated with brief psychedelic...

Is the Prostate a Site of Endogenous DMT Synthesis? A Testable Hypothesis

Zenodo (CERN European Organization for Nuclear Research) October 21, 2026 Shannon Green preprint

Endogenous N,N-dimethyltryptamine (DMT) has been detected in mammals, but its physiological functions and the distribution of functionally relevant synthesis remain unresolved. This paper proposes prostatic tissue as a candidate peripheral site of synthesis. Oncology studies document indolethylamine N-methyltransferase (INMT) expression in human prostate samples, including adjacent...